Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-21

Clinical Trial Update: Sildenafil to Improve Exercise Capacity in People With Thalassemia and Pulmonary Hypertension [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reporting the results of sildenafil for improving exercise capacity in people with thalassemia and pulmonary hypertension in Phase 2/3. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Carelon Research | Conditions: Thalassemia, Hypertension, Pulmonary | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2014-02-21